ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expressionXin Hu(Shanghai Medical College of Fudan University)OncoTargets and TherapyJune 1, 201410.2147/ott.s64759Cited by 15SaveCiteExport RISWatch citationsRelated PapersA novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genome|BMC Nephrology|2021|3Integrative analysis of metabolic subtypes in triple-negative breast cancer reveals new therapeutic strategies|Annals of Oncology|2019|2